Its adjusted earnings per share rises to 25.5 pence, higher than analysts’ expectations Read more at The Business Times.
British pharmaceutical group GSK reported Wednesday a sharp rise in annual net profit, boosted by strong sales of HIV, ...
Nearly nine years ago, when Emma Walmsley was preparing to take over as CEO of GSK Plc, she wrote in her diary that Luke Miels — then an executive at rival AstraZeneca Plc — would be “a dream ...
Emma Walmsley has served as CEO of GlaxoSmithKline since 2017. From the Philadelphia Business Journal. GSK is making a change at the top. The London-based Big Pharma company, which has major ...
GSK needs drugs in the pipeline to offset some significant patent expiries in the next few years, in particular branded ...
LONDON – GSK Chief Executive Emma Walmsley, the first woman to lead a major pharmaceutical company, will step down Dec. 31 after more than eight years at the head of the London-based drugmaker.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results